NCT01226342

Brief Summary

Transcutaneous electrical muscle stimulation (TCEMS) is well established intervention for rehabilitation of clinically stable patients with chronic obstructive pulmonary disease. The investigators have conceived this study to test whether TCEMS is feasible and tolerated by patients experiencing severe physical and psychical challenge of acutely exacerbated COPD.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for not_applicable chronic-obstructive-pulmonary-disease

Timeline
Completed

Started Jan 2009

Shorter than P25 for not_applicable chronic-obstructive-pulmonary-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2009

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2009

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2009

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

October 18, 2010

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 22, 2010

Completed
Last Updated

April 11, 2013

Status Verified

April 1, 2013

Enrollment Period

5 months

First QC Date

October 18, 2010

Last Update Submit

April 10, 2013

Conditions

Keywords

Chronic obstructive pulmonary disease

Outcome Measures

Primary Outcomes (1)

  • Scores on the feasibility scale

    Patients will be followed from admission until discharge

    10 days (avarage time from admission to discharge)

Secondary Outcomes (5)

  • Scores on the patient satisfaction scale

    10 days (avarage time from admission to discharge)

  • Number of patients with adverse events as a measure of Safety and tolerability

    10 days (avarage time from admission to discharge)

  • Health related quality of life on the St. George respiratory questionnaire

    10 days (avarage time from admission to discharge)

  • Dyspnea on the MRC dyspnea scale

    10 days (avarage time from admission to discharge)

  • Patient symptom scores on the Functional assessment of chronic illness therapy questionaire

    10 days (avarage time from admission to discharge)

Study Arms (1)

TCEMS

EXPERIMENTAL

Patients who will receive transcutaneous electrical muscle stimulation

Device: Transcutaneous electrical muscle stimulation

Interventions

On the first hospitalization day patients received lower extremity TCEMS. We used GymnaUniphy device (GymnaUniphy N.V., 2004, 3740 Bilzen, Belgium) with four surface patch electrodes applied over each lower extremity quadriceps muscle. Patients were in the supine position and were advised to relax during sessions. A prespecified program for lower extremity strength training in sessions of 25 minutes, twice a day (first training in the morning, second in the afternoon, with minimal time difference of 6 hours) was performed six days per week during the hospitalization.

TCEMS

Eligibility Criteria

Age35 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • chronic obstructive pulmonary disease GOLD stage III or IV
  • acute exacerbation of the disease

You may not qualify if:

  • contraindications for transcutaneous electrical muscle stimulation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Clinic Golnik

Golnik, SI-4204, Slovenia

Location

Related Publications (1)

  • Meglic U, Sorli J, Kosnik M, Lainscak M. Feasibility of transcutaneous electrical muscle stimulation in acute exacerbation of COPD. Wien Klin Wochenschr. 2011 Jun;123(11-12):384-7. doi: 10.1007/s00508-011-1587-2. Epub 2011 May 25.

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Mitja Lainscak, MD, PhD

    University Clinic Golnik

    PRINCIPAL INVESTIGATOR
  • Mitja Kosnik, MD, PhD

    contraindications for TCEMS

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

October 18, 2010

First Posted

October 22, 2010

Study Start

January 1, 2009

Primary Completion

June 1, 2009

Study Completion

October 1, 2009

Last Updated

April 11, 2013

Record last verified: 2013-04

Locations